The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 6, 2013, Pages 1553-1561

  Guedes, Renata P ^a   Rocha, Eduardo ^a,b   Mahiou, Jerome ^a,c   Moll, Herwig P ^a   Arvelo, Maria B ^a   Taube, Janis M ^a,d   Peterson, Clayton R ^a   Kaczmarek, Elzbieta ^a   Longo, Christopher R ^a,e   da Silva, Cleide G ^a   Ferran, Christiane ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Escoublac   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e Carolina Vascular Surgery   (United States)

Author keywords

A1 Bfl 1; Apoptosis; C terminal domain; Mitochondria; Nuclear Factor Kappa B

Indexed keywords

ADENOVIRUS VECTOR; BCL2 RELATED PROTEIN A1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; STAUROSPORINE;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIUM CELL; ENDOTHELIUM CELL; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; CATTLE; CELL PROLIFERATION; DERMIS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUCIFERASES; NF-KAPPA B; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

ADENOVIRIDAE; BOVINAE;

EID: 84876071367     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.03.001     Document Type: Article

References (38)

1. Lin E.Y., Orlofsky A., Berger M.S., Prystowsky M.B. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 1993, 151:1979-1988.
2. Choi S.S., Park I.C., Yun J.W., Sung Y.C., Hong S.I., Shin H.S. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 1995, 11:1693-1698.
3. Jourdan M., Reme T., Goldschmidt H., Fiol G., Pantesco V., De Vos J., Rossi J.F., Hose D., Klein B. Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells. Br. J. Haematol. 2009, 145:45-58.
4. Karsan A., Yee E., Kaushansky K., Harlan J.M. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996, 87:3089-3096.
5. Stroka D.M., Badrichani A.Z., Bach F.H., Ferran C. Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. Blood 1999, 93:3803-3810.
6. Kunter U., Daniel S., Arvelo M.B., Choi J., Shukri T., Patel V.I., Longo C.R., Scali S.T., Shrikhande G., Rocha E., Czismadia E., Mottley C., Grey S.T., Floege J., Ferran C. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Kidney Int. 2005, 68:1520-1532.
7. Sarkar S.A., Kutlu B., Velmurugan K., Kizaka-Kondoh S., Lee C.E., Wong R., Valentine A., Davidson H.W., Hutton J.C., Pugazhenthi S. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009, 52:1092-1101.
8. Badrichani A.Z., Stroka D.M., Bilbao G., Curiel D.T., Bach F.H., Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J. Clin. Invest. 1999, 103:543-553.
9. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 2007, 7:803-815.
10. Bach F.H., Hancock W.W., Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol. Today 1997, 18:483-486.
11. Brien G., Debaud A.L., Robert X., Oliver L., Trescol-Biemont M.C., Cauquil N., Geneste O., Aghajari N., Vallette F.M., Haser R., Bonnefoy-Berard N. C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1. J. Biol. Chem. 2009, 284:30257-30263.
12. D'Sa-Eipper C., Chinnadurai G. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene 1998, 16:3105-3114.
13. Herman M., Nyman T., Welin M., Lehtio L., Flodin S., Tresaugues L., Kotenyova T., Flores A., Nordlund P. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett. 2008, 582:3590-3594.
14. 4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis. J. Biol. Chem. 1999, 274:20415-20420.
15. Huang D.C.S., Adams J.M., Cory S. The conserved N-terminal BH4 domain of BCl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 1998, 17:1029-1039.
16. Lindsay J., Esposti M.D., Gilmore A.P. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim. Biophys. Acta Mol. Cell Res. 2010, 1813:532-539.
17. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., Ferran C. A20 blocks endothelial cell activation through a NF-kB-dependent mechanism. J. Biol. Chem. 1996, 271:18068-18073.
18. Richard L., Velasco P., Detmar M. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp. Cell Res. 1998, 240:1-6.
19. Ferran C., Stroka D.M., Badrichani A.Z., Cooper J.T., Wrighton C.J., Soares M., Grey S.T., Bach F.H. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 1998, 91:2249-2258.
20. Aiyar A., Xiang Y., Leis J. Site-directed mutagenesis using overlap extension PCR. Methods Mol. Biol. 1996, 57:177-191.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Duriez P.J., Wong F., Dorovini-Zis K., Shahidi R., Karsan A. A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J. Biol. Chem. 2000, 275:18099-18107.
23. Werner A.B. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit its collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 2002, 277:22781-22788.
24. Herold M.J. The stability and anti-apoptotic function of A1 are controlled by its C terminus. J. Biol. Chem. 2006, 281:13663-13671.
25. Lee E.G., Boone D.L., Chai S., Libby S.L., Chein J., Lodolce J.P., Ma A. Failure to regulate TNF-induced NF-kB and cell death responses in A20-deficient mice. Science 2000, 289:2350-2354.
26. Kucharczak J.F., Simmons M.J., Duckett C.S., Gelinas C. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor. Cell Death Differ. 2005, 12:1225-1239.
27. Yang W.S., Ko J.K., Park S.O., Choi H.Y., Kim Y.N., Kim C.W. C-terminal region of Bfl-1 induces cell death that accompanies caspase activation when fused with GFP. J. Cell. Biochem. 2005, 94:1234-1247.
28. Crosio C., Casciati A., Iaccarino C., Rotilio G., Carrì M.T. Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis. Cell Death Differ. 2006, 13:2150-2153.
29. Simmons M.J., Fan G., Zong W.X., Degenhardt K., White E., Gélinas C. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene 2007, 27:1421-1428.
30. Antonsson B., Conti F., Ciavatta A.M., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.C. Inhibition of Bax channel-forming activity by Bcl-2. Science 1997, 370-372.
31. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608.
32. Ko J.-K., Lee M.-J., Cho S.-H., Cho J.-A., Lee B.-Y., Koh J.S., Lee S.-S., Shim Y.-H., Kim C.-W. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 2003, 22:2457-2465.
33. Hamasaki A., Sendo F., Nakayama K., Ishida N., Negishi I., Hatakeyama S. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J. Exp. Med. 1998, 188:1985-1992.
34. Bilbao G., Contreras J.L., Mikheeva G., Krasnykh V., Eckhoff D.E., Thomas F.T., Thomas J., Curiel D.T. Genetic cytoprotection of human endothelial cells during preservation time with an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene. Transplant. Proc. 1999, 31:1012-1015.
35. Karsan A., Yee E., Harlan J.M. Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 1996, 271:27201-27204.
36. Iwata A., Morgan-Stevenson V., Schwartz B., Liu L., Tupper J., Zhu X., Harlan J., Winn R. Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury. PLoS One 2010, 5:e9103.
37. Jenal M., Batliner J., Reddy V.A., Haferlach T., Tobler A., Fey M.F., Torbett B.E., Tschan M.P. The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia 2010, 24:1073-1076.
38. Olsson A., Norberg M., ökvist A., Derkow K., Choudhury A., Tobin G., Celsing F., österborg A., Rosenquist R., Jondal M., Osorio L.M. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br. J. Cancer 2007, 97:769-777.